Prothena Corp PLC (PRTA)
25.10
-0.97
(-3.72%)
USD |
NASDAQ |
Mar 18, 16:00
25.12
+0.02
(+0.08%)
After-Hours: 20:00
Prothena Free Cash Flow: -136.72M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -136.72M |
September 30, 2023 | -89.26M |
June 30, 2023 | -129.63M |
March 31, 2023 | -119.35M |
December 31, 2022 | -109.28M |
September 30, 2022 | -126.94M |
June 30, 2022 | 16.26M |
March 31, 2022 | 88.31M |
December 31, 2021 | 92.03M |
September 30, 2021 | 95.66M |
June 30, 2021 | -35.72M |
March 31, 2021 | -91.08M |
December 31, 2020 | -80.56M |
September 30, 2020 | -76.01M |
June 30, 2020 | -65.72M |
March 31, 2020 | -59.15M |
December 31, 2019 | -53.52M |
September 30, 2019 | -61.52M |
June 30, 2019 | -86.05M |
March 31, 2019 | -15.84M |
December 31, 2018 | -30.04M |
September 30, 2018 | -47.36M |
June 30, 2018 | -31.91M |
Date | Value |
---|---|
March 31, 2018 | -126.23M |
December 31, 2017 | -134.81M |
September 30, 2017 | -135.86M |
June 30, 2017 | -156.20M |
March 31, 2017 | -147.94M |
December 31, 2016 | -132.89M |
September 30, 2016 | -108.75M |
June 30, 2016 | -87.38M |
March 31, 2016 | -70.53M |
December 31, 2015 | -59.98M |
September 30, 2015 | -55.76M |
June 30, 2015 | -50.89M |
March 31, 2015 | -33.82M |
December 31, 2014 | -1.209M |
September 30, 2014 | 1.548M |
June 30, 2014 | 3.388M |
March 31, 2014 | -9.581M |
December 31, 2013 | -32.66M |
September 30, 2013 | -39.49M |
June 30, 2013 | -36.51M |
March 31, 2013 | -39.82M |
December 31, 2012 | -43.37M |
Free Cash Flow Range, Past 5 Years
-136.72M
Minimum
Dec 2023
95.66M
Maximum
Sep 2021
-52.20M
Average
-70.86M
Median
Free Cash Flow Benchmarks
Amarin Corp PLC | 6.347M |
Jazz Pharmaceuticals PLC | 1.049B |
Iterum Therapeutics PLC | -30.81M |
GH Research PLC | -33.44M |
Mural Oncology PLC | -- |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -51.04M |
Cash from Investing (Quarterly) | -1.512M |
Cash from Financing (Quarterly) | 0.483M |
Free Cash Flow Per Share (Quarterly) | -0.9798 |
Free Cash Flow to Equity (Quarterly) | -52.59M |
Free Cash Flow to Firm (Quarterly) | -52.59M |
Free Cash Flow Yield | -10.02% |